Navigation Links
Amylin Pharmaceuticals to Present Compelling Efficacy and Safety Data From Diabetes Programs at ADA 2009
Date:5/29/2009

SAN DIEGO, May 29 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today announced that the company will present data for its FDA-approved diabetes drugs, BYETTA(R) (exenatide) injection and SYMLIN(R) (pramlintide acetate) injection, and its investigational diabetes drug candidate exenatide once weekly at the American Diabetes Association's (ADA's) 69th Annual Scientific Sessions being held in New Orleans from June 5 to 9. The company will also host an investor presentation and webcast on Sunday, June 7, at 7:45 PM CT (8:45 PM ET). The annual meeting of the ADA is one of the largest scientific meetings for endocrinologists and other health care professionals involved in diabetes research and diabetes care.

Amylin will be introducing data through 16 posters and five oral presentations at the meeting. The data being presented will demonstrate significant progress in key research and clinical programs for BYETTA, exenatide once weekly and SYMLIN. Additional information will be presented during two corporate-sponsored symposia focused on the potential of peptide therapy treatment approaches for type 2 diabetes, and the role of incretin-based therapies in relation to type 2 diabetes.

"Presentations at ADA will highlight compelling efficacy and safety data for BYETTA, exenatide once weekly and SYMLIN. The data presented at ADA will further demonstrate Amylin's progress in bringing life-changing therapies to market," said Daniel M. Bradbury, president and chief executive officer of Amylin Pharmaceuticals, Inc. "We look forward to this year's ADA and are pleased to have the opportunity to contribute to a body of work that is focused on improving the lives of people living with diabetes."

KEY AMYLIN ABSTRACTS BEING PRESENTED AT ADA

  1. Oral: "Exenatide Once Weekl
    '/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Amylin Announces Preliminary Results of Annual Meeting of Stockholders
2. Amylin Advises All Shareholders to Vote Their Blue Proxy Card Today
3. Three Independent Proxy Advisory Firms Support Stockholder Nominees in Amylin Proxy Fight
4. Amylin Issues Statement Regarding Open Letter From Icahn
5. Icahn Issues Open Letter to Amylin Shareholders
6. Amylin Sends Letter to Shareholders
7. Amylin Pharmaceuticals Reports First Quarter Financial Results
8. Letter From Carl Icahn to Amylin Pharmaceutical, Inc.
9. Amylin Pharmaceuticals to Webcast First Quarter Results
10. Amylin Pharmaceuticals Announces Slate of Directors for Annual Meeting of Stockholders
11. Amylin Pharmaceuticals Comments on Shareholder 13-D Filing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... care client base, with the recent implementation of Microsoft Dynamics GP for a ... the industry, Intellitec is now supporting senior living communities in 16 states. This ...
(Date:7/31/2015)... ... 2015 , ... David Gilpin, M.D., a board certified otolaryngologist ... Nashville area sinus sufferers about the benefits of Balloon Sinuplasty. , The ... a good candidate for Balloon Sinuplasty. The questionnaire asks questions about symptoms and ...
(Date:7/30/2015)... ... July 31, 2015 , ... When responsible for the care of an aging ... race through your mind: What happens if mom falls? Who will remind Dad to ... your plans. , But not taking time away from caregiving responsibilities can lead to ...
(Date:7/30/2015)... ... July 31, 2015 , ... Reduce Human Error on ... by FDAnews and Ginette M. Collazo, Inc.**, Sept. 16-17, 2015 – Raleigh, NC, ... drug, biologic and device firms reduce manufacturing errors by 50 percent or more, ...
(Date:7/30/2015)... ... ... On July 22nd the Bradenton Herald reported the Opioid Task ... the heroin outbreak. Ultimately the committee expressed lack of funding, and the absence of ... in North Florida. The task force has proposed to instate counselors to meet with ...
Breaking Medicine News(10 mins):Health News:Intellitec Solutions Expands Long term Care ERP Offerings to Maine 2Health News:Nashville Otolaryngologist Dr. David Gilpin Launches Balloon Sinuplasty Website 2Health News:Nashville Otolaryngologist Dr. David Gilpin Launches Balloon Sinuplasty Website 3Health News:Aging Life Care Association™ Experts Offer Tips for Caregivers in Need of Vacation Time 2Health News:Aging Life Care Association™ Experts Offer Tips for Caregivers in Need of Vacation Time 3Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 2Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 3Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 4Health News:Manatee County’s Opioid Task Force Calls for More Funding and Face to Face Counseling After Overdose 2Health News:Manatee County’s Opioid Task Force Calls for More Funding and Face to Face Counseling After Overdose 3
... come a long way in the time since Neurologist Dr. David ... on call, I was paged to the emergency department for a ... the cafeteria, I was told to go ahead and finish my ... Now doctors know "time is brain," and the faster an ...
... an identification error sends a chill down the spine ... Amanita phalloides ), which resembles the common white button ... in nature, α-amanitin. This substance kills any cell without ... German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and the ...
... HealthDay Reporter , SUNDAY, April 1 (HealthDay ... women who take estrogen-only hormone replacement to treat menopause ... cancer, another, much-larger study finds that when used for ... woman,s long-term risk for breast cancer. The new ...
... Center have uncovered more details about how defects in components ... blood and other cancers. The findings, which will be ... 2, may one day lead to new targeted therapies that ... in one class of proteins can trigger the development of ...
... SATURDAY, March 31 (HealthDay News) -- A noninvasive scan ... cancer and help guide treatment, researchers report. The ... so far only been tested successfully in mice. But ... York City said the technology could help identify cases ...
... , SATURDAY, March 31 (HealthDay News) -- Research on ... virus can be published in full, U.S. government biosecurity ... use the information to start a pandemic. The ... papers, which have been revised since they were first ...
Cached Medicine News:Health News:Stroke experts write a doctor's guide for minimizing the risk of stroke 2Health News:Death cap mushroom poison to arrest pancreatic cancer in mice 2Health News:Death cap mushroom poison to arrest pancreatic cancer in mice 3Health News:Long-Term Estrogen Therapy Does Up Breast Cancer Risk: Study 2Health News:Long-Term Estrogen Therapy Does Up Breast Cancer Risk: Study 3Health News:Researchers uncover new clues to the development of blood and other cancers 2Health News:New Scanning Technology Might Help Guide Prostate Cancer Care 2Health News:New Scanning Technology Might Help Guide Prostate Cancer Care 3Health News:U.S. Advisers Say It's Now Safe to Publish Bird Flu Studies 2
(Date:7/30/2015)... , July 30, 2015  ResMed ... has signed a definitive agreement to acquire ... non-invasive ventilation and sleep-disordered breathing medical devices ... innovation and market reputation in China, combined with ResMed,s global leadership in sleep ... in China suffering ...
(Date:7/30/2015)... , July 30, 2015  EP Global ... executives have recently contacted the Company about discussing ... as early as Monday, August 3, 2015.  Novartis ... as saying that the coming electronic contact lens ... dollars over the next several years.  Novartis partnered ...
(Date:7/30/2015)... 30, 2015  Amgen (NASDAQ: AMGN ) ... of 2015. Key results include: , Total ... of 2014 to $5,370 million, with 6 percent ... (etanercept), Prolia ® (denosumab), Sensipar ® ... ® (denosumab). Unfavorable changes in foreign exchange ...
Breaking Medicine Technology:ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 20Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 21Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 22Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 23
... epTIPS Filter have an integrated ... without "self-sealing" additives. This filter provides ... by aerosols, and it does not ... incorrect pipetting. Samples can then be ...
... Designed To Mark The X & Y ... For Accurate Axial Alignment. 11mm Inner Diameter & ... Limbus. , ,Removes The Guess Work Associated With Hand-Held ... Tonometer Tip Slit-Lamp Housing To Ensure A More ...
Inquire...
... bottom allows easy withdrawal of solution ,• ... Nesting ring allows easy separation ... 4, 8, and 12 channel pipettors. Angled ... of practically all of the solution. The ...
Medicine Products: